4.5 Article

Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults

期刊

NEUROBIOLOGY OF AGING
卷 105, 期 -, 页码 57-63

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2021.04.009

关键词

Blood pressure variability; Cerebral perfusion; Alzheimer's disease; Aging

资金

  1. NIH/NIA [R01AG064228, R01AG060049, R21AG055034, P50 AG005142, P01 AG052350]
  2. NSF [DGE1418060]
  3. Alzheimer's Associa-tion grant [AARG-17-532905]
  4. Alzheimer's Disease Neuroimaging Ini-tiative (ADNI) (National Institutes of Health) [U01 AG024904]
  5. DOD ADNI (Department of Defense) [W81XWH1220012]
  6. National Institute on Aging
  7. National Institute of Biomedical Imaging and Bioengineering
  8. Alzheimer's Association
  9. Alzheimer's Drug Discovery Foundation
  10. Araclon Biotech
  11. Biogen
  12. Bristol-Myers Squibb Company
  13. CereSpir, Inc.
  14. Cogstate
  15. Elan Pharmaceuticals, Inc.
  16. Eli Lilly and Company
  17. EuroImmun
  18. F. Hoffmann-La Roche Ltd
  19. Fujirebio
  20. Johnson & Johnson Pharmaceutical Research & Development LLC.
  21. Merck Co., Inc.
  22. Meso Scale Diagnostics
  23. NeuroRx Research
  24. Novartis Pharmaceuticals Corporation
  25. Pfizer Inc.
  26. Piramal Imaging
  27. Takeda Pharmaceutical Company
  28. Canadian Institutes of Health Research
  29. ADNI clinical sites in Canada
  30. Northern California Institute for Research and Education
  31. Laboratory for Neuro Imaging at the University of Southern California
  32. U.S. Department of Defense (DOD) [W81XWH1220012] Funding Source: U.S. Department of Defense (DOD)

向作者/读者索取更多资源

Research shows that increased blood pressure variability in older adults is associated with a decline in regional cerebral perfusion, potentially serving as an early marker of vascular dysfunction in aging.
Blood pressure variability (BPV) is linked to dementia risk, possibly through cerebral hypoperfusion. We investigated BPV over 1 year and concurrent regional cerebral perfusion decline in older adults without dementia. Participants underwent 4 blood pressure measurements across 12 months, ASL-MRI at baseline and 12-months, and baseline FDG-PET. Regional perfusion was normalized to precentral gyrus. A subset had cerebral spinal fluid Alzheimer's disease biomarker abnormalities. For every SD increase in BPV, per -fusion decreased in medial orbitofrontal cortex (ss =-.36; p = 0.008), hippocampus (ss =-.37; p = 0.005), entorhinal cortex (ss =-.48; p < 0.001), precuneus (ss =-.31; p = 0.02), inferior parietal cortex (ss =-.44; p < 0.001), and inferior temporal cortex (ss =-.46; p < 0.001). Similar patterns emerged in subsets with biomarker abnormalities. Older adults with elevated BPV exhibit concurrent regional perfusion decline in areas vulnerable to Alzheimer's disease, independent of cerebral hypometabolism. BPV may be an early marker of vascular dysfunction in aging. (c) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据